• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LU103793(NSC D - 669356):一种与微管相互作用并抑制有丝分裂的合成肽。

LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.

作者信息

de Arruda M, Cocchiaro C A, Nelson C M, Grinnell C M, Janssen B, Haupt A, Barlozzari T

机构信息

BASF Bioresearch Corporation, Worcester, Massachusetts 01605-4314, USA.

出版信息

Cancer Res. 1995 Jul 15;55(14):3085-92.

PMID:7606731
Abstract

LU103793 (NSC D-669356) is a new synthetic derivative of Dolastatin 15, an antiproliferative compound which was isolated from the mollusk Dolabella auricularia. Like Dolastatin 15, LU103793 is highly cytotoxic in vitro (IC50 = 0.1 nM). To investigate the mechanism of action of LU103793, we used a combination of biochemical and cellular methods. Turbidity assays with bovine brain microtubules demonstrated that LU103793 inhibits microtubule polymerization in a concentration-dependent manner (IC50 = 7 microM). Treatment with this compound also induced depolymerization of preassembled microtubules. Cell cycle analysis of tumor cell lines treated with LU103793 indicated a block in the G2-M phase. At the cellular level, it induced depolymerization of microtubules in interphase cells and development of abnormal spindles and chromosome distribution in mitotic cells. Although these effects are very similar to the cellular alterations caused by vinblastine, LU103793 does not inhibit vinblastine binding to unpolymerized tubulin in vitro. Our results suggest that LU103793 exerts its cytotoxic activity primarily through disruption of microtubule organization.

摘要

LU103793(NSC D - 669356)是多拉司他汀15的一种新型合成衍生物,多拉司他汀15是一种从软体动物耳状芋螺中分离得到的抗增殖化合物。与多拉司他汀15一样,LU103793在体外具有高度细胞毒性(IC50 = 0.1 nM)。为了研究LU103793的作用机制,我们结合了生化和细胞方法。用牛脑微管进行的浊度测定表明,LU103793以浓度依赖的方式抑制微管聚合(IC50 = 7 microM)。用该化合物处理还诱导了预组装微管的解聚。对用LU103793处理的肿瘤细胞系进行细胞周期分析表明,细胞在G2 - M期受阻。在细胞水平上,它诱导间期细胞中的微管解聚,并在有丝分裂细胞中导致异常纺锤体和染色体分布。尽管这些效应与长春碱引起的细胞改变非常相似,但LU103793在体外并不抑制长春碱与未聚合微管蛋白的结合。我们的结果表明,LU103793主要通过破坏微管组织发挥其细胞毒性活性。

相似文献

1
LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.LU103793(NSC D - 669356):一种与微管相互作用并抑制有丝分裂的合成肽。
Cancer Res. 1995 Jul 15;55(14):3085-92.
2
Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.海绵抑素1,一种具有高度细胞毒性、源自海绵的海洋天然产物,可抑制有丝分裂、微管组装以及长春碱与微管蛋白的结合。
Mol Pharmacol. 1993 Oct;44(4):757-66.
3
Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.塞马多汀与微管蛋白结合对微管动力学的抑制作用:其抗肿瘤作用的可能机制
Biochemistry. 1998 Dec 15;37(50):17571-8. doi: 10.1021/bi9817414.
4
A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.A-204197,一种新型微管蛋白结合剂,对已知微管抑制剂耐药的肿瘤细胞系具有抗有丝分裂活性。
Cancer Res. 2001 Jul 15;61(14):5480-5.
5
Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation.大蒜衍生化合物S-烯丙基半胱氨酸(SAMC)诱导细胞凋亡与微管解聚和c-Jun氨基末端激酶1激活有关。
Cancer Res. 2003 Oct 15;63(20):6825-37.
6
Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.多拉司他汀15,一种从耳状珊瑚藻中提取的强效抗有丝分裂缩肽。与微管蛋白的相互作用及对细胞微管的影响。
Biochem Pharmacol. 1992 Jun 23;43(12):2637-45. doi: 10.1016/0006-2952(92)90153-a.
7
Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.抗有丝分裂抗真菌化合物苯菌灵通过与微管蛋白中的一个新位点结合,抑制脑微管聚合、动力学以及有丝分裂时的癌细胞增殖。
Biochemistry. 2004 Jun 1;43(21):6645-55. doi: 10.1021/bi036112v.
8
Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin.重氮酰胺A及其合成结构类似物:对有丝分裂和细胞微管的破坏作用及其与微管蛋白相互作用的分析
Mol Pharmacol. 2003 Jun;63(6):1273-80. doi: 10.1124/mol.63.6.1273.
9
3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.3-(碘乙酰胺基)-苯甲酰脲:一种新型的抗癌微管蛋白配体,可抑制微管聚合、使bcl-2磷酸化并诱导肿瘤细胞凋亡。
Cancer Res. 1998 Dec 1;58(23):5389-95.
10
Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.丹酚醛,一种从丹参中分离出的新型微管抑制剂,在多药敏感和耐药的人类肿瘤细胞中具有抗有丝分裂活性。
Mol Pharmacol. 2004 Jan;65(1):77-84. doi: 10.1124/mol.65.1.77.

引用本文的文献

1
(-)-Rhazinilam and the diphenylpyridazinone NSC 613241: Two compounds inducing the formation of morphologically similar tubulin spirals but binding apparently to two distinct sites on tubulin.(-)-Rhazinilam和二苯基哒嗪酮NSC 613241:两种诱导形成形态相似的微管蛋白螺旋但显然结合于微管蛋白上两个不同位点的化合物。
Arch Biochem Biophys. 2016 Aug 15;604:63-73. doi: 10.1016/j.abb.2016.06.008. Epub 2016 Jun 13.
2
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?稳定微管与破坏微管:癌症有效治疗选择的双刃剑?
Anal Cell Pathol (Amst). 2015;2015:690916. doi: 10.1155/2015/690916. Epub 2015 Sep 21.
3
Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.
具有抗癌潜力的生物活性肽和去肽:来自海洋动物的来源。
Mar Drugs. 2012 May;10(5):963-986. doi: 10.3390/md10050963. Epub 2012 Apr 26.
4
Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation.一种用于无铜点击生物共轭的水溶性吡啶二硫化物胺连接剂的应用。
Tetrahedron Lett. 2011 Aug 17;52(33):4316-4319. doi: 10.1016/j.tetlet.2011.06.042.
5
Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity.多拉司他汀15类似物他西多汀的细胞内激活与失活:与细胞毒性的相关性
Mol Pharmacol. 2009 Jan;75(1):218-26. doi: 10.1124/mol.108.051110. Epub 2008 Oct 16.
6
Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.强效抗肿瘤药物TZT-1027与微管蛋白相互作用的表征
Jpn J Cancer Res. 2000 Jul;91(7):737-47. doi: 10.1111/j.1349-7006.2000.tb01007.x.
7
Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs.人结肠癌细胞的分化改变了β-微管蛋白亚型和微管相关蛋白的表达。
Br J Cancer. 1999 Jun;80(8):1162-8. doi: 10.1038/sj.bjc.6690481.
8
Breast cancer therapies in development. A review of their pharmacology and clinical potential.正在研发的乳腺癌治疗方法。对其药理学及临床潜力的综述。
Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003.
9
Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.新型多拉司他汀10衍生物TZT-1027的抗肿瘤活性
Jpn J Cancer Res. 1997 Mar;88(3):316-27. doi: 10.1111/j.1349-7006.1997.tb00383.x.